Patoloxía Molecular das Doenzas Raras
PatMol-DR
University of Sydney
Sídney, AustraliaPublicacións en colaboración con investigadores/as de University of Sydney (3)
2017
-
Evolocumab and clinical outcomes in patients with cardiovascular disease
New England Journal of Medicine, Vol. 376, Núm. 18, pp. 1713-1722
2016
-
The diagnosis and management of lipodystrophy syndromes: A multi-society practice guideline
Journal of Clinical Endocrinology and Metabolism, Vol. 101, Núm. 12, pp. 4500-4511
2008
-
Telmisartan, ramipril, or both in patients at high risk for vascular events
New England Journal of Medicine, Vol. 358, Núm. 15, pp. 1547-1559